Charles Schwab
ZURA icon

Charles Schwab’s Zura Bio ZURA Stock Holding History

Charles Schwab’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
174,395
+143,299
+461% +$682K ﹤0.01% 3001
2026
Q1 		$185K Buy
+31,096
New +$188K ﹤0.01% 3311
2025
Q3 		– Sell
-169,180
Closed -$178K – 3556
2025
Q2 		$178K Sell
169,180
-119,421
-41% -$143K ﹤0.01% 3385
2025
Q1 		$372K Sell
288,601
-7,560
-3% -$11.9K ﹤0.01% 3156
2024
Q4 		$740K Buy
296,161
+4,354
+1% +$15.5K ﹤0.01% 3019
2024
Q3 		$1.18M Buy
291,807
+98,972
+51% +$370K ﹤0.01% 2869
2024
Q2 		$675K Buy
192,835
+9,593
+5% +$39.1K ﹤0.01% 3070
2024
Q1 		$471K Buy
183,242
+4,230
+2% +$15K ﹤0.01% 3050
2023
Q4 		$836K Buy
179,012
+82,915
+86% +$414K ﹤0.01% 2893
2023
Q3 		$634K Buy
96,097
+23,172
+32% +$155K ﹤0.01% 2959
2023
Q2 		$598K Buy
+72,925
New +$586K ﹤0.01% 2966

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Charles Schwab's ZURA Position: Q2 2026 in Review

Charles Schwab increased its Zura Bio (ZURA) stake by 461% in Q2 2026, buying an estimated $682K and bringing the position to 174,395 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3001.

Charles Schwab first reported a position in ZURA in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.18M in Q3 2024. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Charles Schwab held 174,395 shares of Zura Bio worth $1.03M as of Q2 2026.
  • Charles Schwab bought 143,299 Zura Bio shares in Q2 2026, an estimated $682K.
  • Zura Bio made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3001 holding.
  • Charles Schwab first reported a position in Zura Bio in Q2 2023 and has held it in 11 quarters since.
  • Charles Schwab's Zura Bio position peaked at $1.18M in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.